a month ago
MAZE
AnalystsAnupam RamaAnupam Rama's Stock Forecasts
AnalystsAnupam Rama
Sectors:
Analyst Ranking
Top 5%
#223 out of 5272 analysts
Average Return
+14.62%
Win Rate
49%125 out of 254
Risk vs Reward
Poor
Good
Anupam Rama's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Vera Therapeutics IncVERA | +683.63% | $6.23 | $48.82 | 2023-04-12 - 2024-04-11 | Strong Buy |
Cogent Biosciences IncCOGT | +530.49% | $5.51 | $34.74 | 2025-05-29 - 2026-05-08 | Strong Buy |
Maze Therapeutics IncMAZE | +328.57% | $10.57 | $45.30 | 2025-02-25 - 2026-02-24 | Strong Buy |
Vera Therapeutics IncVERA | +267.16% | $13.55 | $49.75 | 2023-11-30 - 2024-11-29 | Strong Buy |
Anaptysbio IncANAB | +261.49% | $16.75 | $60.55 | 2025-03-05 - 2026-03-04 | Strong Buy |
Anupam Rama Analyst Color
Get additional color on Anupam Rama's coverage of popular stocks
2 months ago
CTMX
2 months ago
NBIX
2 months ago
BBIO
2 months ago
SNDX
3 months ago
NBIX
4 months ago
NBIX
6 months ago
ORIC
6 months ago
OLMA
6 months ago
RAPT
6 months ago
DAWN
6 months ago
FOLD
7 months ago
IDYA
7 months ago
COGT
7 months ago
RAPT
a year ago
FOLD
2 years ago
NUVL
2 years ago
TVTX
2 years ago
SWTX
2 years ago
VERA
2 years ago
VERA
2 years ago
ANAB
2 years ago
SLDB
2 years ago
NBIX
2 years ago
ANNX
Anupam Rama's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 22 | Strong Buy | $185.00 | +21.51% | Maintains | 3 days ago |
First Tracks Biotherapeutics IncTRAX | 1 | Strong Buy | $31.00 | +58.65% | Initiates Coverage On | 19 days ago |
Apellis Pharmaceuticals IncAPLS | 14 | Hold | $41.00 | -0.07% | Downgrades | a month ago |
Maze Therapeutics IncMAZE | 3 | Strong Buy | $58.00 | +122.82% | Maintains | a month ago |
Travere Therapeutics IncTVTX | 5 | Strong Buy | $41.00 | -3.76% | Maintains | 2 months ago |
Solid Biosciences IncSLDB | 9 | Strong Buy | $12.00 | +65.06% | Maintains | 2 months ago |
Zai Lab LtdZLAB | 13 | Strong Buy | $32.00 | +72.04% | Maintains | 2 months ago |
Olema Pharmaceuticals IncOLMA | 7 | Strong Buy | $58.00 | +289.26% | Maintains | 2 months ago |
Erasca IncERAS | 2 | Strong Buy | $25.00 | +147.04% | Maintains | 2 months ago |
Cytomx Therapeutics IncCTMX | 3 | Strong Buy | $12.00 | +201.51% | Upgrades | 2 months ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Strong Buy | $74.00 | +183.31% | Maintains | 2 months ago |
Day One Biopharmaceuticals IncDAWN | 6 | Hold | $21.50 | -0.14% | Downgrades | 2 months ago |
Bridgebio Pharma IncBBIO | 11 | Strong Buy | $94.00 | +39.49% | Maintains | 2 months ago |
Syndax Pharmaceuticals IncSNDX | 12 | Strong Buy | $45.00 | +109.40% | Maintains | 2 months ago |
Agomab Therapeutics NvAGMB | 1 | Strong Buy | $32.00 | +163.81% | Initiates Coverage On | 2 months ago |
Vera Therapeutics IncVERA | 12 | Strong Buy | $96.00 | +165.27% | Maintains | 5 months ago |
Cogent Biosciences IncCOGT | 9 | Strong Buy | $67.00 | +92.86% | Maintains | 5 months ago |
Vor Biopharma IncVOR | 2 | Strong Buy | $40.00 | +136.13% | Maintains | 5 months ago |
Nuvalent IncNUVL | 7 | Strong Buy | $145.00 | +37.73% | Maintains | 5 months ago |
Novavax IncNVAX | 1 | Strong Sell | $6.00 | -40.65% | Maintains | 6 months ago |
Oric Pharmaceuticals IncORIC | 7 | Strong Buy | $20.00 | +125.99% | Maintains | 6 months ago |
Enanta Pharmaceuticals IncENTA | 1 | Strong Buy | $17.00 | +10.82% | Initiates Coverage On | 6 months ago |
Rapt Therapeutics IncRAPT | 9 | Strong Buy | $57.00 | -1.76% | Maintains | 6 months ago |
Amicus Therapeutics IncFOLD | 7 | Strong Buy | $19.00 | +31.12% | Maintains | 6 months ago |
Kodiak Sciences IncKOD | 7 | Strong Buy | $24.00 | -41.48% | Upgrades | 7 months ago |
Ideaya Biosciences IncIDYA | 10 | Strong Buy | $79.00 | +178.95% | Maintains | 7 months ago |
Replimune Group IncREPL | 8 | Hold | $11.00 | +170.27% | Upgrades | 7 months ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $200.00 | -9.66% | Initiates Coverage On | 7 months ago |
Sarepta Therapeutics IncSRPT | 14 | Hold | $24.00 | +20.24% | Upgrades | 9 months ago |
Anaptysbio IncANAB | 11 | Strong Buy | $80.00 | +15.39% | Maintains | 10 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 3 | Strong Buy | $40.00 | N/A | Maintains | 2 years ago |
Springworks Therapeutics IncSWTX | 4 | Strong Buy | $68.00 | N/A | Maintains | 2 years ago |
Sage Therapeutics IncSAGE | 7 | Hold | $10.00 | N/A | Maintains | 2 years ago |
Annexon IncANNX | 3 | Strong Buy | $13.00 | N/A | Maintains | 2 years ago |
Generation Bio CoGBIO | 2 | Hold | $90.00 | N/A | Maintains | 3 years ago |
Rallybio CorpRLYB | 2 | Strong Buy | $144.00 | N/A | Maintains | 3 years ago |
G1 Therapeutics IncGTHX | 7 | Hold | $10.00 | N/A | Upgrades | 3 years ago |
Elevation Oncology IncELEV | 2 | Strong Sell | N/A | N/A | Downgrades | 4 years ago |
Mirati Therapeutics IncMRTX | 3 | Strong Buy | $94.00 | N/A | Maintains | 4 years ago |
Atara Biotherapeutics IncATRA | 7 | Hold | $250.00 | N/A | Downgrades | 4 years ago |
Passage Bio IncPASG | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Cytokinetics IncCYTK | 1 | Strong Buy | $58.00 | N/A | Initiates Coverage On | 4 years ago |
Oyster Point Pharma IncOYST | 1 | Hold | $23.00 | N/A | Downgrades | 5 years ago |
Theravance Biopharma IncTBPH | 1 | Hold | $12.00 | N/A | Upgrades | 5 years ago |
Vir Biotechnology IncVIR | 5 | Hold | $37.00 | N/A | Upgrades | 5 years ago |
Protagonist Therapeutics IncPTGX | 2 | Strong Buy | $55.00 | N/A | Upgrades | 5 years ago |
Chemocentryx IncCCXI1 | 3 | Hold | $38.00 | N/A | Upgrades | 5 years ago |
Infinity Pharmaceuticals IncINFI | 2 | Strong Buy | $6.00 | N/A | Upgrades | 5 years ago |
Cyteir Therapeutics IncCYTT | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 5 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Hold | $54.00 | N/A | Downgrades | 5 years ago |
Korro Bio IncKRRO | 3 | Strong Buy | $56.00 | N/A | Upgrades | 5 years ago |
Bioatla IncBCAB | 1 | Strong Buy | $2,250.00 | N/A | Initiates Coverage On | 5 years ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 6 years ago |
Kalaris Therapeutics IncKLRS | 1 | Strong Buy | $1,150.00 | N/A | Initiates Coverage On | 6 years ago |
Iteos Therapeutics IncITOS | 1 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 6 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | $50.00 | N/A | Downgrades | 6 years ago |
Alnylam Pharmaceuticals IncALNY | 2 | Hold | $137.00 | N/A | Downgrades | 6 years ago |
Y Mabs Therapeutics IncYMAB | 1 | Strong Buy | $39.00 | N/A | Initiates Coverage On | 6 years ago |
Dova Pharmaceuticals IncDOVA | 2 | Strong Sell | $20.00 | N/A | Downgrades | 7 years ago |
La Jolla Pharmaceutical CoLJPC | 4 | Hold | $9.00 | N/A | Upgrades | 7 years ago |
Myokardia IncMYOK | 2 | Strong Buy | $81.00 | N/A | Maintains | 8 years ago |
Alexion Pharmaceuticals IncALXN | 2 | Strong Buy | $188.00 | N/A | Maintains | 8 years ago |
Otonomy IncOTIC | 3 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Clearside Biomedical IncCLSDQ | 2 | Strong Buy | $270.00 | N/A | Maintains | 8 years ago |
Inflarx NvIFRX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 8 years ago |
Ptc Therapeutics IncPTCT | 2 | Hold | N/A | N/A | Upgrades | 8 years ago |
Prometheus Biosciences IncRXDX | 1 | Strong Buy | $20.00 | N/A | Maintains | 9 years ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.